Skip to main content
VBIO
NASDAQ Life Sciences

Valion Bio Seeks Shareholder Approval for Reverse Stock Split to Avoid Nasdaq Delisting

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.513
Mkt Cap
$1.64M
52W Low
$0.461
52W High
$5.6
52W Position info
11% above low
Off High info
91% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

VBIO is trading near its 52-week low of $0.461 (11% above the low) on light trading volume (0.1× avg).

Summary

Valion Bio is seeking shareholder approval for a reverse stock split, with a wide ratio range of 1-for-5 to 1-for-50, primarily to regain compliance with Nasdaq's minimum bid price requirement and avoid delisting.


Key Events · Corporate Governance and Compliance · VBIO

  • Reverse Stock Split Proposal

    The Board is seeking shareholder approval to effect a reverse stock split of common stock at a ratio between 1-for-5 and 1-for-50, to be determined by the Board within twelve months.

  • Nasdaq Delisting Threat

    The primary purpose of the reverse split is to regain compliance with Nasdaq's $1.00 minimum bid price requirement, following a deficiency notice received on March 19, 2026, with a compliance deadline of September 15, 2026.

  • Potential for Future Dilution

    The reverse split will not change the number of authorized shares, effectively increasing the proportion of unissued shares available for future capital raises relative to outstanding shares.

  • Special Shareholder Meeting

    A special meeting is scheduled for August 14, 2026, for stockholders to vote on the reverse stock split authorization and a proposal to adjourn the meeting if needed to solicit additional proxies.


Analysis · VBIO · Life Sciences

This preliminary proxy statement reveals Valion Bio's urgent plan to address its Nasdaq minimum bid price deficiency, a critical step to avoid delisting. The proposed reverse stock split, with a wide discretionary range up to 1-for-50, indicates the severity of the company's low share price. While necessary for continued listing, reverse splits are often viewed negatively by the market and do not address underlying business fundamentals. Furthermore, by not reducing the number of authorized shares, the split effectively increases the pool of shares available for future dilutive capital raises, which is a concern given the company's recent 'going concern' warning and ongoing need for capital.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VBIO was trading at $0.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6M. The 52-week trading range was $0.46 to $5.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VBIO - Latest Insights

VBIO
Nov 16, 2026, 4:12 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.510
Real-time Price: $0.473 info
Change: -$0.037 (-7%) info
Market Cap: $1.036M info
VBIO
Nov 05, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.502
Real-time Price: $0.473 info
Change: -$0.029 (-6%) info
Market Cap: $1.036M info
VBIO
Nov 02, 2026, 7:50 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.585
Real-time Price: $0.473 info
Change: -$0.112 (-19%) info
Market Cap: $1.036M info
VBIO
Oct 30, 2026, 7:50 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.6373
Real-time Price: $0.473 info
Change: -$0.1643 (-26%) info
Market Cap: $1.036M info
VBIO
Oct 29, 2026, 7:45 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6758
Real-time Price: $0.473 info
Change: -$0.2028 (-30%) info
Market Cap: $1.036M info